Athanase Innovation AB (ST:ATIN) — Market Cap & Net Worth
Market Cap & Net Worth: Athanase Innovation AB (ATIN)
Athanase Innovation AB (ST:ATIN) has a market capitalization of $52.76 Million (Skr490.27 Million) as of September 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #21788 globally and #397 in its home market, demonstrating a -1.94% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Athanase Innovation AB's stock price Skr20.20 by its total outstanding shares 24270833 (24.27 Million). Also see Athanase Innovation AB (ATIN) total assets for a full breakdown of the balance sheet.
Athanase Innovation AB Market Cap History: 2017 to 2026
Athanase Innovation AB's market capitalization history from 2017 to 2026. Data shows change from $3.39 Billion to $52.76 Million (-36.33% CAGR). Also see Athanase Innovation AB cash flow conversion for how efficiently the company converts equity into cash flow.
Athanase Innovation AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Athanase Innovation AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ATIN stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.43x
Athanase Innovation AB's market cap is 1.43 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $3.77 Billion | $41.18 Million | $7.09 Million | 91.49x | 531.30x |
| 2019 | $4.84 Billion | $42.03 Million | $6.30 Million | 115.22x | 768.27x |
| 2020 | $5.12 Billion | $42.43 Million | $6.19 Million | 120.77x | 827.86x |
| 2022 | $62.16 Million | $7.06 Million | -$26.55 Million | 8.81x | N/A |
| 2023 | $44.40 Million | $6.38 Million | -$114.53 Million | 6.96x | N/A |
| 2024 | $52.76 Million | $40.60 Million | -$56.26 Million | 1.30x | N/A |
| 2025 | $47.01 Million | $176.83 Million | -$19.64 Million | 0.27x | N/A |
| 2026 | $52.76 Million | $36.86 Million | -$57.62 Million | 1.43x | N/A |
Competitor Companies of ATIN by Market Capitalization
Companies near Athanase Innovation AB in the global market cap rankings as of September 19, 2026. Review Athanase Innovation AB tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Athanase Innovation AB by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #142 globally with a market cap of $166.07 Billion USD.
- Blackstone Group Inc (NYSE:BX): Ranked #281 globally with a market cap of $94.05 Billion USD.
- KKR & Co. Inc. (NYSE:KKR): Ranked #299 globally with a market cap of $88.70 Billion USD.
- Brookfield Corporation (TO:BN): Ranked #312 globally with a market cap of $85.27 Billion USD ( CA$117.88 Billion CAD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #142 | BlackRock Inc | NYSE:BLK | $166.07 Billion | $1069.78 |
| #281 | Blackstone Group Inc | NYSE:BX | $94.05 Billion | $124.96 |
| #299 | KKR & Co. Inc. | NYSE:KKR | $88.70 Billion | $98.81 |
| #312 | Brookfield Corporation | TO:BN | $85.27 Billion | CA$52.52 |
Athanase Innovation AB Historical Marketcap From 2017 to 2026
Between 2017 and today, Athanase Innovation AB's market cap moved from $3.39 Billion to $ 52.76 Million, with a yearly change of -36.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr52.76 Million | +12.22% |
| 2025 | Skr47.01 Million | -10.89% |
| 2024 | Skr52.76 Million | +18.82% |
| 2023 | Skr44.40 Million | -28.57% |
| 2022 | Skr62.16 Million | -74.50% |
| 2021 | Skr243.75 Million | -95.24% |
| 2020 | Skr5.12 Billion | +5.79% |
| 2019 | Skr4.84 Billion | +28.55% |
| 2018 | Skr3.77 Billion | +11.04% |
| 2017 | Skr3.39 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Athanase Innovation AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $52.76 Million USD |
| MoneyControl | $52.76 Million USD |
| MarketWatch | $52.76 Million USD |
| marketcap.company | $52.76 Million USD |
| Reuters | $52.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Athanase Innovation AB
Athanase Innovation AB is public venture capital firm specializing in seed funding. The firm primarily invests in private and public technology and innovation companies. It also develops and sells machine inspection unit, used for automatic quality control, inspection and measurement of pallets. The firm typically invests in companies in US and Nordic markets. Athanase Innovation AB was founded i… Read more